Recently, special attention has been paid to SRY-box transcription factor 2 (SOX2), which acts not only as a transcriptional target of ASCL1 [79], but also as a prominent transcription factor that promotes pluripotency in embryonic stem cells [80] and cancer stem cells [81–83]. This evidence concerns the gene SOX2 and cancer.